Your browser doesn't support javascript.
loading
Survival Function of Clinical and Radiographic Success of Three Obturating Materials in Primary Teeth at 3, 6 and 9 Months Periodic Intervals - A Randomized Controlled Clinical Trial.
Kumar, Kandaswamy Saravana; Asokan, Sharath; Geethapriya, P R; Sivakumar, Kailasam; Yamunadevi, Andamuthu.
Affiliation
  • Kumar KS; Department of Paedodontics and Preventive Dentistry, Department of Endodontics, Dhanalakshmi Srinivasan Dental College, Siruvachur, Tamil Nadu, India.
  • Asokan S; Department of Paedodontics and Preventive Dentistry, K.S.R Institute of Dental Science and Research, Tamil Nadu, India.
  • Geethapriya PR; Department of Paedodontics and Preventive Dentistry, KSR Institute of Dental Science and Research, Tamil Nadu, India.
  • Sivakumar K; Department of Paedodontics and Preventive Dentistry, Department of Endodontics, Dhanalakshmi Srinivasan Dental College, Siruvachur, Tamil Nadu, India.
  • Yamunadevi A; Department of Oral Pathology and Microbiology, Dhanalakshmi Srinivasan Dental College, Siruvachur, Perambalur, Tamil Nadu, India.
J Pharm Bioallied Sci ; 15(Suppl 1): S747-S751, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37654309
ABSTRACT
The study aims to assess clinically and radiographically the success of zinc oxide eugenol, metapex, and endoflas as root canal obturating materials in primary teeth over 3, 6, and 9 months of time intervals. The randomized controlled trial was performed in 60 primary molars of 36 children aged between 4 and 9 years. Permanent restorations were given and stainless steel crowns were placed for the treated tooth. Comparing the survival proportion between the three groups was done using the Wilcoxon (Gehans) statistical test. The clinical survival variable showed 100% survival proportion for zinc oxide eugenol and endoflas, while for metapex it was 69% at the end of 9 months. The radiographical survival proportion was 100% for zinc oxide eugenol, followed by endoflas at 92% and 58% for metapex group.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Pharm Bioallied Sci Year: 2023 Document type: Article Affiliation country: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Pharm Bioallied Sci Year: 2023 Document type: Article Affiliation country: India